TLK286 (Telcyta) in Combination With Carboplatin (Paraplatin) Versus Doxil in Platinum Refractory or Resistant Ovarian Cancer
This study has been completed.
Sponsor:
Telik
Information provided by (Responsible Party):
Telik
ClinicalTrials.gov Identifier:
NCT00102973
First received: February 4, 2005
Last updated: May 30, 2012
Last verified: June 2006
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | July 2008 |
| Primary Completion Date: | July 2008 (Final data collection date for primary outcome measure) |